EUVIMEDEUVIMED entdecken
Crossref

In vitro synergistic activity of minocycline and biapenem against cefiderocol-resistant New Delhi metallo-β-lactamase-producing Enterobacterales

Takashi Okanda iD, Niinyo Nakajima, Tetsuo Yamaguchi, Takuro Koshikawa, Tadatomo Oyanagi, Tomonori Takano, Hiroyuki Kunishima, Mitsuo Kaku, Hiromu Takemura

Journal of Antimicrobial Chemotherapy · 03.04.2026 · 81 (5)

DOI: 10.1093/jac/dkag128 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Antimicrobial Chemotherapy, online erschienen am 07.04.2026. Verfasst von Takashi Okanda und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, St.Marianna University School of Medicine, Kanagawa, Japan. Hauptthemen laut MEDLINE: Drug Synergism, Minocycline, Anti-Bacterial Agents, beta-Lactamases. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 25 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Cefiderocol is an important treatment option for infections caused by multidrug-resistant Gram-negative bacteria; however, resistance among New Delhi metallo-β-lactamase-producing Enterobacterales (NDME) is increasingly reported, leaving limited therapeutic alternatives. This study evaluated the in vitro activity of the minocycline–biapenem combination against cefiderocol-resistant NDME.

Methods

Twenty-three non-duplicate clinical NDME isolates with cefiderocol MIC ≥ 16 mg/L determined by reference broth microdilution in iron-depleted cation-adjusted Mueller–Hinton broth were analysed. Checkerboard assays were performed to assess combination activity using fractional inhibitory concentration indices (FICIs), sub-MIC interaction analysis and cumulative inhibition heatmaps. Time–kill assays were conducted using three representative isolates producing NDM-1 or NDM-5.

Results

Susceptibility rates for minocycline and biapenem tested alone were 52% and 13%, respectively. The minocycline–biapenem combination demonstrated synergistic activity (FICI ≤ 0.5) in 22 of 23 isolates (96%), with a median FICI of 0.063. Synergy was consistently observed across Escherichia coli, Enterobacter cloacae and Klebsiella pneumoniae. Sub-MIC analyses revealed asymmetric pharmacodynamic interactions, with sustained reductions in biapenem MIC at minocycline exposures as low as 1/512× baseline MIC. Cumulative inhibition heatmaps showed growth inhibition in 100% of isolates at the susceptible breakpoint concentrations of minocycline (4 mg/L) and biapenem (1 mg/L). Time–kill assays confirmed rapid and exposure-dependent bactericidal activity at clinically achievable concentration pairs.

Conclusions

The minocycline–biapenem combination showed consistent in vitro synergistic and bactericidal activity against cefiderocol-resistant NDME across multiple species and NDM variants. These findings support further pharmacodynamic and translational evaluation of this combination as a potential therapeutic option for cefiderocol-refractory infections.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug SynergismMinocyclineAnti-Bacterial Agentsbeta-LactamasesCephalosporinsEnterobacteriaceaeThienamycinsCefiderocolMicrobial Sensitivity TestsHumansEnterobacteriaceae InfectionsDrug Resistance, Multiple, Bacterial

Substanzen

CefiderocolMinocyclineAnti-Bacterial Agentsbeta-LactamasesCephalosporinsbiapenemThienamycinsbeta-lactamase NDM-1

Autor:innen und Institutionen

  • Department of Microbiology, St.Marianna University School of Medicine, Kanagawa, Japan.
  • Department of Clinical Laboratory Technology, St.Marianna University Hospital, Kanagawa, Japan.
  • Department of Infectious Diseases, St.Marianna University School of Medicine, Kanagawa, Japan.

ORCID-Profile: Takashi Okanda

Förderung

  • Japan Society for the Promotion of Science

Zitieren

APA

Okanda, T., Nakajima, N., Yamaguchi, T., Koshikawa, T., Oyanagi, T., Takano, T., Kunishima, H., Kaku, M., & Takemura, H. (2026). In vitro synergistic activity of minocycline and biapenem against cefiderocol-resistant New Delhi metallo-β-lactamase-producing Enterobacterales. Journal of Antimicrobial Chemotherapy, 81(5). https://doi.org/10.1093/jac/dkag128

Vancouver

Okanda T, Nakajima N, Yamaguchi T, Koshikawa T, Oyanagi T, Takano T, et al. In vitro synergistic activity of minocycline and biapenem against cefiderocol-resistant New Delhi metallo-β-lactamase-producing Enterobacterales. Journal of Antimicrobial Chemotherapy. 2026;81(5). doi:10.1093/jac/dkag128

BibTeX
@article{Okanda2026,
  author = {Okanda, Takashi and Nakajima, Niinyo and Yamaguchi, Tetsuo and Koshikawa, Takuro and Oyanagi, Tadatomo and Takano, Tomonori and Kunishima, Hiroyuki and Kaku, Mitsuo and Takemura, Hiromu},
  title = {In vitro synergistic activity of minocycline and biapenem against cefiderocol-resistant New Delhi metallo-β-lactamase-producing Enterobacterales},
  journal = {Journal of Antimicrobial Chemotherapy},
  year = {2026},
  volume = {81},
  number = {5},
  doi = {10.1093/jac/dkag128}
}
Kostenlos starten →